Literature DB >> 9085170

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus.

M Malaguarnera1, I Di Fazio, M A Romeo, S Restuccia, A Laurino, B A Trovato.   

Abstract

Interleukin 6 (IL-6) is a pleiotropic cytokine produced by a wide variety of lymphoid and non-lymphoid tissues. We studied the relationship between IL-6 and the liver in an attempt to elucidate this cytokine's role in hepatitis C-induced liver inflammation. We investigated the behavior of serum IL-6 in 25 patients with chronic hepatitis C (divided into three groups depending on severity) and in 27 healthy controls. Our results showed a significant elevation (P < 0.0001) in serum IL-6 levels in the patients with chronic hepatitis C, correlated with the histological activity index (HAI) and their HCV-RNA serum levels. This rise may represent the expression of the hepatitis C virus-induced inflammatory state.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9085170     DOI： 10.1007/bf02936370

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  20 in total

1.  Monokine gene expression in normal human liver: selective involvement of the portal compartment.

Authors:  D Emilie; E Navratil; O Devergne; M Reynes; M C Crevon; D Samuel; P Galanaud
Journal:  Liver       Date:  1992-02

2.  The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21.

Authors:  A M Bowcock; J R Kidd; G M Lathrop; L Daneshvar; L T May; A Ray; P B Sehgal; K K Kidd; L L Cavalli-Sforza
Journal:  Genomics       Date:  1988-07       Impact factor: 5.736

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Interleukin-6 in hepatitis C cirrhosis.

Authors:  M Malaguarnera; B A Trovato; A Laurino; I Di Fazio; M A Romeo; M Motta
Journal:  Panminerva Med       Date:  1996-12       Impact factor: 5.197

5.  Human chromosome 7 carries the beta 2 interferon gene.

Authors:  P B Sehgal; A Zilberstein; R M Ruggieri; L T May; A Ferguson-Smith; D L Slate; M Revel; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Interleukin-6 release by rat liver macrophages.

Authors:  K J Busam; T M Bauer; J Bauer; W Gerok; K Decker
Journal:  J Hepatol       Date:  1990-11       Impact factor: 25.083

7.  Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes.

Authors:  H Schooltink; T Stoyan; E Roeb; P C Heinrich; S Rose-John
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

8.  Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease.

Authors:  H Hagiwara; N Hayashi; E Mita; M Naito; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1993-04       Impact factor: 17.425

9.  [Role of interleukin 6 in hepatocellular carcinoma].

Authors:  M Malaguarnera; I Di Fazio; A Laurino; M A Romeo; I Giugno; B A Trovato
Journal:  Bull Cancer       Date:  1996-05       Impact factor: 1.276

10.  Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages.

Authors:  L S Feder; J A Todaro; D L Laskin
Journal:  J Leukoc Biol       Date:  1993-02       Impact factor: 4.962
View more
  26 in total

1.  Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.

Authors:  Michael Reid; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Audrey L French; Michael W Plankey; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

2.  Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Authors:  Yusuke Funaoka; Naoya Sakamoto; Goki Suda; Yasuhiro Itsui; Mina Nakagawa; Sei Kakinuma; Takako Watanabe; Kako Mishima; Mayumi Ueyama; Izumi Onozuka; Sayuri Nitta; Akiko Kitazume; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Bradley J Anderson; Michael D Stein
Journal:  J Addict Dis       Date:  2011-04

4.  Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.

Authors:  Banchob Sripa; Eimorn Mairiang; Bandit Thinkhamrop; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Smarn Tessana; Alex Loukas; Paul J Brindley; Jeffrey M Bethony
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

5.  Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.

Authors:  Judith I Tsui; Marlene C Lira; Debbie M Cheng; Michael R Winter; Daniel P Alford; Jane M Liebschutz; Jianren Mao; Robert R Edwards; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2015-05-22       Impact factor: 4.492

6.  Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Fabio D'Antona; Ada-Maria Florena; Emanuele La Spada; Angela Terranova; Melchiorre Cervello; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 7.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

8.  Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.

Authors:  Wang-Sheng Ko; Chih-Hung Guo; Maw-Sheng Yeh; Li-Yun Lin; Guoo-Shyng W Hsu; Pei-Chung Chen; Mei-Ching Luo; Chia-Yeh Lin
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

9.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  Efficacy of MK615 for the treatment of patients with liver disorders.

Authors:  Atsushi Hokari; Tomohisa Ishikawa; Hisao Tajiri; Takahide Matsuda; Osamu Ishii; Nobuyuki Matsumoto; Chiaki Okuse; Hideaki Takahashi; Takeshi Kurihara; Ko-Ichi Kawahara; Ikuro Maruyama; Mikio Zeniya
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.